According to Markntel Advisors Report, Chronic Lower Back Pain Market is expected to grow at a significant growth rate, and the analysis period is 2025-2030, considering the base year as 2024.Consistent monitoring and evaluating of market dynamics to stay informed and adapt your strategies accordingly. As a market research and consulting firm, we offer market research reports that focus on major parameters including Target Market Identification, Customer Needs and Preferences, Thorough Competitor Analysis, Market Size & Market Analysis, and other major factors. At the end, we do provide meaningful insights and actionable recommendations that inform decision-making and strategy development.

Chronic Lower Back Pain Market Research Report & Summary:

The Global Chronic Lower Back Pain Market size was valued at around USD 2.8 billion in 2024 and is projected to reach USD 4.7 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 9% during the forecast period, i.e., 2025-30.                   

Time Period Captured in the Report:

·        Historical Years: 2020-2023

·        Base Years: 2024

·        Forecast Years: 2025-2030

Who are the Key Players Operating in the Chronic Lower Back Pain Market?

The top companies of the Chronic Lower Back Pain Market ruling the industry are: 

Johnson & Johnson Services, Inc., Pfizer Inc., Vertebral Technologies, Inc., Merck & Co., Medtronic plc, Boston Scientific Corporation, Mesoblast Limited, Stayble Therapeutics, Eli Lilly and Company, NuVasive, OrthoPediatrics, Smith Nephew, Stryker, DePuy Synthes, Spinal Elements, and others

Our Latest Reports Now Include In-Depth Supply Chain Ecosystem Analysis, Enabling Businesses to Navigate Tariff Challenges with Greater Agility Get Sample Report- https://www.marknteladvisors.com/query/request-sample/chronic-lower-back-pain-market.html

("Kindly use your official email ID for all correspondence to ensure seamless engagement and access to exclusive benefits, along with prioritized support from our sales team.")

What is included in Chronic Lower Back Pain Market Segmentation?

The Chronic Lower Back Pain Market explores the industry by emphasizing the growth parameters and categorizes including geographical segmentation, to offer a comprehensive understanding of the market dynamic.  The further bifurcations are as follows:

• By Pain Type
• Neuropathic Pain -Market Size & Forecast 2020-2030, USD Million
• Arthritis Pain-Market Size & Forecast 2020-2030, USD Million
• Cancer Pain-Market Size & Forecast 2020-2030, USD Million
• Migraine-Market Size & Forecast 2020-2030, USD Million
• Other-Market Size & Forecast 2020-2030, USD Million
• By Drug Class
• Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)-Market Size & Forecast 2020-2030, USD Million
• Opioids-Market Size & Forecast 2020-2030, USD Million
• Analgesics-Market Size & Forecast 2020-2030, USD Million
• Antidepressants-Market Size & Forecast 2020-2030, USD Million
• Other-Market Size & Forecast 2020-2030, USD Million
• By Drug Type
• OTC-Market Size & Forecast 2020-2030, USD Million
• Aspirin-Market Size & Forecast 2020-2030, USD Million
• Naproxen-Market Size & Forecast 2020-2030, USD Million
• Other-Market Size & Forecast 2020-2030, USD Million
• Prescription-Market Size & Forecast 2020-2030, USD Million
• By Route of Administration
• Oral-Market Size & Forecast 2020-2030, USD Million
• Topical-Market Size & Forecast 2020-2030, USD Million
• Other-Market Size & Forecast 2020-2030, USD Million
• By Distribution Channel
• Hospital Pharmacy-Market Size & Forecast 2020-2030, USD Million
• Retail Pharmacy-Market Size & Forecast 2020-2030, USD Million
• Online Pharmacy-Market Size & Forecast 2020-2030, USD Million
• By Region
• North America
• South America
• Europe
• The Middle East & Africa
• Asia-Pacific

Explore the Complete Chronic Lower Back Pain Market Analysis Report – https://www.marknteladvisors.com/research-library/chronic-lower-back-pain-market.html

Chronic Lower Back Pain Market Driver:

Growing Elderly Population Worldwide Creating Demand – This problem is partly attributed to aging as one of the major factors that derive the market demand. The growing elderly population globally is driving the demand due to the commonness of chronic lower back pain among that particular age group. As per the World Health Organization, the population is aging at a rapid rate with 1 of every 6 individuals expected to be at or above 60 years of age by 2030. The aged population will grow from 1 billion in 2020 to approx. 1.4 billion in 2030 and further to approx. 2.1 billion by 2050. Elderly people over the age group of 60 are majorly affected with chronic lower back pain making it one of the most significant disabling diseases in that age group. For instance, chronic low back pain ubiquity in the Brazilian older population is as high as 25.4%. This is due to the rising pain that is associated with degenerative joints in the spine which is more likely to occur among older adults.

For instance, as per the National Institute of Health (NIH) in 2021, approx. 80% of the elderly are expected to suffer from some kind of lower back pain throughout their life. Out of them around 25% are expected to suffer from chronic back pain at any given time. Hence, the rising elderly population and the prevalence of lower back pain in the elderly are creating the requirement for medicines & treatments that are driving the market demand.

Need personalized insights? Click here to customize this report- https://www.marknteladvisors.com/query/request-customization/chronic-lower-back-pain-market.html

Why Markntel Advisor Report?

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

For Further Queries:

Contact Us

MarkNtel Advisors

Email at -sales@marknteladvisors.com

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh - 201301, India